Why is Lincoln Pharma. falling/rising?

As of 13-Nov, Lincoln Pharmaceuticals Ltd is experiencing a decline in its stock price, currently at Rs. 508.00, which reflects a decrease of Rs. 18.2 or 3.46%. The stock has hit a new 52-week low of Rs. 491 today, indicating significant downward pressure. It has underperformed its sector by 3.67% and has fallen after two consecutive days of gains. Additionally, the stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, suggesting a bearish trend. The stock's performance over various periods shows a year-to-date decline of 35.78% compared to a gain of 8.11% in the benchmark Sensex, further highlighting its struggles in the market.
In the broader market context, the stock's short-term performance has been notably weaker than the benchmark, with a 1-week return of -2.86% compared to the Sensex's gain of 1.40%. This underperformance indicates that investor sentiment towards Lincoln Pharmaceuticals is currently negative, despite a rise in delivery volume by 95.87% against the 5-day average, which suggests some increased investor participation. However, the overall liquidity remains adequate for trading, but the prevailing trends and recent price movements indicate a challenging environment for the stock.